SCHEMBL585347

SCHEMBL585347

[S]Sc1cccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9548473 0.81 CYP2A6 (0.50) —
SCHEMBL2829221 0.81 ALDH1A1 (0.50) —
SCHEMBL29896037 0.81 ALDH1A1 (0.50) —
Hydrochloric Acid SCHEMBL30967433 0.79 ALDH1A1 (0.48) —
Hydrochloric Acid SCHEMBL10942983 0.79 ALDH1A1 (0.48) —
SCHEMBL23183097 0.77 — —
SCHEMBL272036 0.77 — —
SCHEMBL12317161 0.77 — —
SCHEMBL21415461 0.77 — —
Ethyne SCHEMBL17596309 0.77 ALDH1A1 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160251409-A1 Targeted Delivery of Factor VIII Proteins to Platelets NOVO NORDISK AS (DK) 2016-09-01 — — US disclosed
EP-2417155-B1 TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS NOVO NORDISK AS (DK) 2013-06-19 — — EP disclosed
US-20120093840-A1 TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS NOVO NORDISK A/S (DK) 2012-04-19 — — US disclosed
EP-2417155-A1 TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS Novo Nordisk A/S (DK) 2012-02-15 — — EP disclosed
WO-2010115866-A1 TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS NOVO NORDISK A/S (DK) 2010-10-14 — — WO disclosed
Send feedback